Press Release

SK Biopharmaceuticals' Proteovant Therapeutics Presents Preclinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

New data presented on novel orally bioavailable p300-selective degraders showing significant anti-tumor activity in preclinical models of androgen receptor (AR) positive prostate cancer SEOUL, South Korea and KING OF PRUSSIA, Pa., Oct. 13, 2023 /PRNewswire/ — SK Biopharmaceuticals, a global biotech focused on the research, development and commercialization of treatments for disorders of the central nervous system (CNS) and […]

Read More
Press Release

OKX Showcases Commitment to the Bahamas at D3 FinTech Festival

OKX Chief Innovation Officer Jason Lau exclusive interview: "The Future of Digital Asset Exchanges" OKX Chief Global Government Relations Officer Tim Byun speaking panel: "Trust and cooperation: how should the innovator-regulator relationship work?" OKX Head of Compliance Bahamas Ianthe Tynes speaking panel: "A Caribbean Web3 Future" NASSAU, Bahamas, Oct. 12, 2023 /PRNewswire/ — OKX, a […]

Read More
Press Release

Avature Announces the General Release of its Social Learning Solution

LONDON, Oct. 13, 2023 /PRNewswire/ — Avature, a leading provider of innovative Human Capital Management (HCM) software for recruiting and talent management, announces the beta release of its social learning solution to a select group of customers, and a general release before the end of this year. Industry reports indicate a very low and steadily […]

Read More
Press Release

CARsgen's CAR-GPC3 T-cell Therapy for Advanced Hepatocellular Carcinoma: Two Patients Achieved over 7 Years of Disease-free Survival

SHANGHAI, Oct. 12, 2023 /PRNewswire/ — CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announced the publication of two cases of long-term disease-free survival in the treatment of advanced hepatocellular carcinoma (HCC) with CARsgen’s innovative CAR-GPC3 T-cell therapy. These […]

Read More
Press Release

GameChange Solar Announces Landmark Deal For Supplying Solar Trackers To Support 560 MW Capacity In Egypt

NORWALK, Conn., Oct. 13, 2023 /PRNewswire/ — GameChange Solar, a global provider of solar racking solutions, announced today that it has entered into an agreement to supply solar tracker systems to support a 560 MW capacity solar project in Egypt with CEEC-ZTPC, an engineering, procurement and construction ("EPC") company headquartered in China with energy project […]

Read More
Press Release

Grid Endless Aisle Powers Feridras Kiosks in Italy

STOCKHOLM, Oct. 12, 2023 /PRNewswire/ — OmboriGrid, in collaboration with ITAB Shop Concept, have developed a customized version of their Grid Endless Aisle solution for Feridras kiosks in DIY and home improvement stores in Italy.   Feridras manufactures a wide range of bathroom furniture and accessories, which they sell via resellers throughout Italy. The company’s product […]

Read More
Press Release

Akeso Announced The Lancet Oncology Publishes Promising Clinical Results from Cadonilimab in Patients with Advanced Solid Tumours (COMPASSION-03/AK104-201)

HONG KONG, Oct. 12, 2023 /PRNewswire/ — Akeso, Inc. (9926.HK) ("Akeso") announced that the results of the multicenter, open-label Phase Ib/II clinical trial (COMPASSION-03/AK104-201) for cadonilimab (PD-1/CTLA-4 bispecific antibody), the globally first bispecific IO drug used to treat advanced solid tumors, have been published in the October 2 issue of The Lancet Oncology. This multicenter […]

Read More

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.